Nammi Therapeutics, Inc.

Nammi Therapeutics is an immunotherapy company dedicated to developing novel cancer treatments that leverage the power of the immune system while mitigating the severe side effects associated with traditional systemic approaches. Their focus is on developing products that selectively activate the immune system within the tumor microenvironment, sparing healthy tissues from the damaging effects of potent immune modulators.

Nammi’s core technology platforms, Masked ImmunoCytokines (MICs) and Nammisomes, are designed to address the key challenges of immunotherapy. MICs combine tumor-targeting antibodies with masked cytokines, ensuring targeted delivery and activation within tumors. Nammisomes utilize lipid nanoparticles to encapsulate multiple immunotherapy mechanisms of action, enhancing efficacy and reducing development time/costs. Nammi’s innovative approach has led to promising preclinical data and the company is currently pursuing clinical trials for their lead programs, QXL138AM and SLNP-IC1.

Nammi Therapeutics is an immunotherapy company focused on developing novel treatments for cancer that are designed to activate the immune system specifically at the tumor site, while minimizing the systemic side effects often associated with traditional immunotherapies. They leverage two complementary platforms: Masked ImmunoCytokines (MICs) and Nammisomes, which both incorporate mechanisms to selectively target and activate immune modulators within tumors. This approach aims to improve treatment efficacy and patient safety by focusing the immune response directly on the cancer, while minimizing damage to healthy tissues.

Nammi Therapeutics promotes a collaborative and innovative culture, attracting a world-class scientific team with extensive experience in drug discovery and development. They prioritize building a strong, diverse team of individuals with a shared passion for advancing immuno-oncology and developing first-in-class treatments for cancer. This is reflected in their commitment to fostering a positive work environment where employees are encouraged to share ideas, contribute to the company's success, and make a real difference in the lives of patients.

Nammi Therapeutics does not explicitly state its approach to diversity, equity, and inclusion on its website.